David Moadel

David Moadel

InvestorPlace Contributor

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

Get in the Pole Position with Electric Vehicle SPAC Gores Guggenheim

By David Moadel, InvestorPlace Contributor

Polestar has big plans for the next few years. At the same time, GGPI stock is slipping -- but that's a chance to pick up some cheap shares.

CRISPR Therapeutics Is One of Today’s Best Biotech Value Investments

By David Moadel, InvestorPlace Contributor

Don't let the downtrend in CRSP stock fool you; the company is still making headway in advancing potentially life-changing therapeutics.

After Post-IPO Rise and Pullback, Expensify Doesn’t Look Expensive

By David Moadel, InvestorPlace Contributor

The market is still figuring out a price range for recently launched EXFY stock. However, it's worth owning if you can handle the volatility.

Catch the Wave of Cloud-Business Acceleration with DigitalOcean Holdings

By David Moadel, InvestorPlace Contributor

DOCN stock went too high, too fast. After a sharp pullback, however, it's open season for dip buyers who like DigitalOcean's revenue growth.

$20 Price Prediction Is Ambitious but Possible for Biofrontera

By David Moadel, InvestorPlace Contributor

BFRI stock is an imperfect investment as Biofrontera isn't currently profitable, but a new patent could provide a significant revenue source.

Load More